Synthesis of Imidazole-Based Medicinal Molecules Utilizing the van Leusen Imidazole Synthesis
Abstract
:1. Introduction
2. General van Leusen Imidazole Synthesis
3. Developments of the van Leusen Imidazole Synthesis
4. Other van Leusen Imidazole Synthesis
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Mishra, R.; Ganguly, S. Imidazole as an anti-epileptic: An overview. Med. Chem. Res. 2012, 21, 3929–3939. [Google Scholar] [CrossRef]
- Zhang, L.; Peng, X.M.; Damu, G.L.; Geng, R.X.; Zhou, C.H. Comprehensive review in current developments of imidazole-based medicinal chemistry. Med. Res. Rev. 2014, 34, 340–437. [Google Scholar] [CrossRef]
- Gaba, M.; Mohan, C. Development of drugs based on imidazole and benzimidazole bioactive heterocycles: Recent advances and future directions. Med. Chem. Res. 2015, 25, 173–210. [Google Scholar] [CrossRef]
- Fan, Y.L.; Jin, X.H.; Huang, Z.P.; Yu, H.F.; Zeng, Z.G.; Gao, T.; Feng, L.S. Recent advances of imidazole-containing derivatives as anti-tubercular agents. Eur. J. Med. Chem. 2018, 150, 347–365. [Google Scholar] [CrossRef] [PubMed]
- Daraji, D.G.; Prajapati, N.P.; Patel, H.D. Synthesis and applications of 2-substituted imidazole and its derivatives: A review. J. Heterocycl. Chem. 2019, 56, 2299–2317. [Google Scholar] [CrossRef]
- Khabnadideh, S.; Rezaci, Z.; Khalafi, N.A.; Motazedian, M.H.; Eskandari, M. Synthesis of metronidazole derivatives as antigiardiasis agents. DARU 2007, 15, 17–20. [Google Scholar]
- Satyanarayana, V.; Sivakumar, A. An efficient and novel one-pot synthesis of 2,4,5-triaryl-1H-imidazoles catalyzed by UO2(NO3)2·6H2O under heterogeneous conditions. Chem. Pap. 2011, 65, 519–526. [Google Scholar] [CrossRef]
- Van den, B.H. Biochemical effects of miconazole on fungi—I Effects on the uptake and/or utilization of purines, pyrimidines, nucleosides, amino acids and glucose by Candida albicans. Biochem. Pharmacol. 1974, 23, 887–899. [Google Scholar]
- Carrilo-Muñoz, A.J.; Tur, C.; Torres, J.; Seymour, A.C. In-Vitro antifungal activity of sertaconazole, bifonazole, ketoconazole, and miconazole against yeasts of the Candida genus. J. Antimicrob. Chemother. 1996, 37, 815–819. [Google Scholar] [CrossRef] [Green Version]
- Che, H.; Tuyen, T.N.; Kim, H.P.; Park, H. 1,5-Diarylimidazoles with strong inhibitory activity against COX-2 catalyzed PGE2 production from LPS-induced RAW 264.7 cells. Bioorg. Med. Chem. Lett. 2010, 20, 4035–4037. [Google Scholar] [CrossRef]
- Forster, L.; Ludwig, J.; Kaptur, M.; Bovens, S.; Elfringhoff, A.S.; Holtfrerich, A.; Lehr, M. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase. Bioorg. Med. Chem. 2010, 18, 945–952. [Google Scholar] [CrossRef] [PubMed]
- Ren, J.S.; Nichols, C.; Bird, L.E.; Fujiwara, T.; Sugimoto, H.; Stuart, D.I.; Stammers, D.K. Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding. J. Biol. Chem. 2000, 275, 14316–14320. [Google Scholar] [CrossRef] [Green Version]
- Zhan, P.; Liu, X.; Zhu, J.; Fang, Z.; Li, Z.; Pannecouque, C.; Clercq, E.D. Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorg. Med. Chem. 2009, 17, 5775–5781. [Google Scholar] [CrossRef] [PubMed]
- Valdez, C.A.; Tripp, J.C.; Miyamoto, Y.; Kalisiak, J.; Hruz, P.; Andersen, Y.S.; Brown, S.E.; Kangas, K.; Arzu, L.V.; Davids, B.J.; et al. Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia. J. Med. Chem. 2009, 52, 4038–4053. [Google Scholar] [CrossRef] [Green Version]
- Kapoor, V.K.; Chadha, R.; Venisetty, P.K.; Prasanth, S. Medicinal significance of nitroimidazoles-Some recent advances. J. Sci. Ind. Res. 2003, 62, 659–665. [Google Scholar]
- Josephy, P.D.; Palcic, B.; Skarsgard, L.D. In Vitro metabolism of misonidazole. Br. J. Cancer 1981, 43, 443–450. [Google Scholar] [CrossRef] [Green Version]
- Pectasides, D.; Yianniotis, H.; Alevizakos, N.; Bafaloukos, D.; Barbounis, V.; Varthalitis, J.; Dimitriadis, M.; Athanassiou, A. Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin. Br. J. Cancer 1989, 60, 627–629. [Google Scholar] [CrossRef] [Green Version]
- Kitbunnadaj, R.; Zuiderveld, O.P.; Christophe, B.; Hulscher, S.; Menge, W.M.; Gelens, E.; Snip, E.; Bakker, R.A.; Celanire, S.; Gillard, M.; et al. Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H3 receptor agonist. J. Med. Chem. 2004, 47, 2414–2417. [Google Scholar] [CrossRef]
- Motawaj, M.; Arrang, J.M. Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, modulates methamphetamine-induced sensitization in mice. Eur. J. Neurosci. 2011, 33, 1197–1204. [Google Scholar] [CrossRef]
- Hille, U.E.; Zimmer, C.; Vock, C.A.; Hartmann, R.W. First selective CYP11B1 inhibitors for the treatment of cortisol-dependent diseases. ACS Med. Chem. Lett. 2011, 2, 2–6. [Google Scholar] [CrossRef] [Green Version]
- Salerno, L.; Modica, M.N.; Romeo, G.; Pittala, V.; Siracusa, M.A.; Amato, M.E.; Acquaviva, R.; Di Giacomo, C.; Sorrenti, V. Novel inhibitors of nitric oxide synthase with antioxidant properties. Eur. J. Med. Chem. 2012, 49, 118–126. [Google Scholar] [CrossRef] [PubMed]
- Van Leusen, A.M.; Wildeman, J.; Oldenziel, O.H. Base-induced cycloaddition of sulfonylmethyl isocyanides to C,N double bonds. Synthesis of 1,5-disubstituted and 1,4,5-trisubstituted imidazoles from aldimines and imidoyl chlorides. J. Org. Chem. 1977, 42, 1153–1159. [Google Scholar] [CrossRef]
- Ma, B.B.; Peng, Y.X.; Zhao, P.C.; Huang, W. cis and trans Isomers distinguished by imidazole N-alkylation after Debus-Radziszewski reaction starting from 2,7-di-tert-butyl-pyrene-4,5,9,10-tetraone. Tetrahedron 2015, 71, 3195–3202. [Google Scholar] [CrossRef]
- Benincori, T.; Brenna, E.; Sannicolo, F. Studies on Wallach’s imidazole synthesis. J. Chem. Soc. Perkin Trans. 1993, 1, 675–679. [Google Scholar] [CrossRef]
- Tandon, V.K.; Rai, S. p-Toluenesulfonylmethyl isocyanide: A versatile synthon in organic chemistry. Suljiur Rep. 2003, 24, 307–385. [Google Scholar]
- Akritopoulou-Zanze, I. Isocyanide-based multicomponent reactions in drug discovery. Curr. Opin. Chem. Biol. 2008, 12, 324–331. [Google Scholar] [CrossRef]
- Lujan-Montelongo, J.A.; Estevez, A.O.; Fleming, F.F. Alkyl sulfinates: Formal nucleophiles for synthesizing TosMIC analogs. Eur. J. Org. Chem. 2015, 7, 1602–1605. [Google Scholar] [CrossRef]
- Mathiyazhagan, A.D.; Anilkumar, G. Recent advances and applications of p-toluenesulfonylmethyl isocyanide (TosMIC). Org. Biomol. Chem. 2019, 17, 6735–6747. [Google Scholar] [CrossRef]
- Van Leusen, D.; van Leusen, A.M. Synthetic uses of tosylmethyl isocyanide (TosMIC). In Organic Reactions; Overman, L., Ed.; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2001; Volume 57, pp. 417–666. [Google Scholar]
- Frankowski, A.; Deredas, D.; Lenouen, D.; Tschamber, T.; Streith, J. On the way to glycoprocessing inhibitors. Synthesis of an imidazo-L-xylo-piperidinose derivative. Helv. Chim. Acta 1995, 78, 1837–1842. [Google Scholar] [CrossRef]
- Sisko, J. A one-pot synthesis of 1-(2,2,6,6-tetramethyl-4-piperidinyl)-4-(4-fluorophenyl)-5-(2-amino-4-pyrimidinyl)-imidazole: A potent inhibitor of P38 MAP kinase. J. Org. Chem. 1998, 63, 4529–4531. [Google Scholar] [CrossRef]
- Sisko, J.; Kassick, A.J.; Mellinger, R.; Filan, J.J.; Allen, A.; Olsen, M.A. An investigation of imidazole and oxazole syntheses using aryl-substituted TosMIC reagents. J. Org. Chem. 2000, 65, 1516–1524. [Google Scholar] [CrossRef] [PubMed]
- Vanelle, P.; Meuche, J.; Maldonado, J.; Crozet, M.P.; Delmas, F.; Timon-David, P. Functional derivatives of 5-benzo[1,3]-5-yl-1-methyl-1H-imidazole-2-carbaldehyde and evaluation of leishmanicidal activity. Eur. J. Med. Chem. 2000, 35, 157–162. [Google Scholar] [CrossRef]
- Gracias, V.; Gasiecki, A.F.; Djuric, S.W. Synthesis of fused bicyclic imidazoles by sequential van Leusen/ring-closing metathesis reactions. Org. Lett. 2005, 7, 3183–3186. [Google Scholar] [CrossRef] [PubMed]
- Gracias, V.; Gasiecki, A.F.; Djuric, S.W. Synthesis of fused imidazo azepine derivatives by sequential van Leusen/enyne metathesis reactions. Tetrahedron Lett. 2005, 46, 9049–9052. [Google Scholar] [CrossRef]
- Gracias, V.; Darczak, D.; Gasiecki, A.F.; Djuric, S.W. Synthesis of fused triazolo-imidazole derivatives by sequential van Leusen/alkyne–azide cycloaddition reactions. Tetrahedron Lett. 2005, 46, 9053–9056. [Google Scholar] [CrossRef]
- Beebe, X.; Gracias, V.; Djuric, S.W. Synthesis of fused imidazo-pyridine and -azepine derivatives by sequential van Leusen/Heck reactions. Tetrahedron Lett. 2006, 47, 3225–3228. [Google Scholar] [CrossRef]
- Gracias, V.; Gasiecki, A.F.; Pagano, T.G.; Djuric, S.W. Synthesis of fused imidazole rings by sequential van Leusen/C–H bond activation. Tetrahedron Lett. 2006, 47, 8873–8876. [Google Scholar] [CrossRef]
- Beck, B.; Leppert, C.A.; Mueller, B.K.; Dömling, A. Discovery of pyrroloimidazoles as agents stimulating neurite outgrowth. QSAR Comb. Sci. 2006, 25, 527–535. [Google Scholar] [CrossRef]
- Domling, A.; Beck, B.; Herdtweck, E.; Antuch, W.; Oefner, C.; Yehia, N.; Gracia-Marques, A. Parallel synthesis of arrays of 1,4,5-trisubstituted 1-(4-piperidyl)-imidazoles by IMCR: A novel class of aspartyl protease inhibitors. Arkivoc 2007, 2007, 99–109. [Google Scholar]
- Fodili, M.; Nedjar-Kolli, B.; Garrigues, B.; Lherbet, C.; Hoffmann, P. Synthesis of imidazoles from ketimines using tosylmethyl isocyanide (TosMIC) catalyzed by bismuth triflate. Lett. Org. Chem. 2009, 6, 354–358. [Google Scholar] [CrossRef]
- De Moliner, F.; Hulme, C. A van Leusen deprotection-cyclization strategy as a fast entry into two imidazoquinoxaline families. Tetrahedron Lett. 2012, 53, 5787–5790. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fallarini, S.; Massarotti, A.; Gesu, A.; Giovarruscio, S.; Zabetta, G.C.; Bergo, R.; Giannelli, B.; Brunco, A.; Lombardi, G.; Sorba, G.; et al. In silico-driven multicomponent synthesis of 4,5-and 1,5-disubstituted imidazoles as indoleamine 2,3-dioxygenase inhibitors. Med. Chem. Comm. 2016, 7, 409–419. [Google Scholar] [CrossRef]
- Murugesh, V.; Harish, B.; Adiseshu, M.; Nanubolu, J.B.; Suresh, S. Tandem copper-catalyzed N-arylation-condensation and van Leusen reaction: Synthesis of 1,4-benzodiazepines and imidazobenzodiazepines (ImBDs). Adv. Synthesis Catal. 2016, 358, 1309–1321. [Google Scholar] [CrossRef]
- Hogendorf, A.S.; Hogendorf, A.; Kurczab, R.; Satala, G.; Lenda, T.; Walczak, M.; Latacz, G.; Handzlik, J.; Kiec-Kononowicz, K.; Wieronska, J.M.; et al. Low-basicity 5-HT7 receptor agonists synthesized using the van Leusen multicomponent protocol. Sci. Rep. 2017, 7, 1444. [Google Scholar] [CrossRef] [PubMed]
- Hogendorf, A.S.; Hogendorf, A.; Popiolek-Barczyk, K.; Ciechanowska, A.; Mika, J.; Satala, G.; Walczak, M.; Latacz, G.; Handzlik, J.; Kiec-Kononowicz, K.; et al. Fluorinated indole-imidazole conjugates: Selective orally bioavailable 5-HT7 receptor low-basicity agonists, potential neuropathic painkillers. Eur. J. Med. Chem. 2019, 170, 261–275. [Google Scholar] [CrossRef]
- Saha, D.; Kaur, T.; Sharma, A. Facile construction of imidazo-benzothia-/oxazepines via quick and efficient van Leusen protocol. Asian J. Org. Chem. 2017, 6, 527–533. [Google Scholar] [CrossRef]
- Brant, M.G.; Goodwin-Tindall, J.; Stover, K.R.; Stafford, P.M.; Wu, F.; Meek, A.R.; Schiavini, P.; Wohnig, S.; Weaver, D.F. Identification of potent indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors based on a phenylimidazole scaffold. ACS Med. Chem. Lett. 2018, 9, 131–136. [Google Scholar] [CrossRef]
- Kondaparla, S.; Manhas, A.; Dola, V.R.; Srivastava, K.; Puri, S.K.; Katti, S.B. Design, synthesis and antiplasmodial activity of novel imidazole derivatives based on 7-chloro-4-aminoquinoline. Bioorg. Chem. 2018, 80, 204–211. [Google Scholar] [CrossRef]
- Savanur, H.M.; Kalkhambkar, R.G.; Laali, K.K. Libraries of C-5 substituted imidazoles and oxazoles by sequential van Leusen (vL)-Suzuki, vL-Heck and vL-Sonogashira in imidazolium-ILs with piperidine-appended-IL as base. Eur. J. Org. Chem. 2018, 38, 5285–5288. [Google Scholar] [CrossRef]
- Guan, Z.R.; Liu, Z.M.; Ding, M.W. New efficient synthesis of 1H-imidazo-[4,5-c]quinolines by a sequential van Leusen/Staudinger/aza-Wittig/carbodiimide-mediated cyclization. Tetrahedron 2018, 74, 7186–7192. [Google Scholar] [CrossRef]
- Lammi, C.; Sgrignani, J.; Arnoldi, A.; Lesma, G.; Spatti, C.; Silvani, A.; Grazioso, G. Computationally driven structure optimization, synthesis, and biological evaluation of imidazole-based proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors. J. Med. Chem. 2019, 62, 6163–6174. [Google Scholar] [CrossRef] [PubMed]
- Rashamuse, T.J.; Harrison, A.T.; Mosebi, S.; van Vuuren, S.; Coyanis, E.M.; Bode, M.L. Design, synthesis and biological evaluation of imidazole and oxazole fragments as HIV-1 integrase-LEDGF/p75 disruptors and inhibitors of microbial pathogens. Bioorg. Med. Chem. 2020, 28, 115210. [Google Scholar] [CrossRef]
- Bunev, A.S.; Vasiliev, M.A.; Statsyuk, V.E.; Ostapenko, G.I.; Peregudov, A.S. Synthesis of 1-aryl-4-tosyl-5-(trifluoromethyl)-1H-imidazoles. J. Fluor. Chem. 2014, 163, 34–37. [Google Scholar] [CrossRef]
- Bunev, A.S.; Varakina, E.V.; Khochenkov, D.A.; Peregudov, A.S. 1-Imidoyl-1,2,3-benzotriazoles—Novel reagents for the synthesis of 1-aryl-5-trifluoromethylimidazoles. Russ. J. Org. Chem. 2019, 55, 493–497. [Google Scholar] [CrossRef]
- Fodili, M.; Nedjar-Kolli, B.; Vedrenne, M.; Saffon-Merceron, N.; Lherbet, C.; Hoffmann, P. The first example of an unusual rearrangement in the van Leusen imidazole synthesis. Chem. Heterocycl. Compd. 2015, 51, 940–943. [Google Scholar] [CrossRef]
- Satyam, K.; Murugesh, V.; Suresh, S. The base-free van Leusen reaction of cyclic imines on water: Synthesis of N-fused imidazo 6,11-dihydro β-carboline derivatives. Org. Biomol. Chem. 2019, 17, 5234–5238. [Google Scholar] [CrossRef] [PubMed]
- Necardo, C.; Alfano, A.I.; Del Grosso, E.; Pelliccia, S.; Galli, U.; Novellino, E.; Meneghetti, F.; Giustiniano, M.; Tron, G.C. Aryl azides as forgotten electrophiles in the van Leusen reaction: A multicomponent transformation affording 4-Tosyl-1-arylimidazoles. J. Org. Chem. 2019, 84, 16299–16307. [Google Scholar] [CrossRef]
- Geigle, S.N.; Petersen, A.C.; Satz, A.L. Development of DNA-Compatible van Leusen three-component imidazole synthesis. Org. Lett. 2019, 21, 9001–9004. [Google Scholar] [CrossRef]
Pharmacological Activities | Chemical Structures | |
---|---|---|
Antibacterial | | |
Antifungal | | |
Anti-inflammatory | | |
Antiviral | | |
Antiparasitic | | |
Anticancer | | |
Antihistaminic | | |
Enzyme inhibitor | | |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zheng, X.; Ma, Z.; Zhang, D. Synthesis of Imidazole-Based Medicinal Molecules Utilizing the van Leusen Imidazole Synthesis. Pharmaceuticals 2020, 13, 37. https://doi.org/10.3390/ph13030037
Zheng X, Ma Z, Zhang D. Synthesis of Imidazole-Based Medicinal Molecules Utilizing the van Leusen Imidazole Synthesis. Pharmaceuticals. 2020; 13(3):37. https://doi.org/10.3390/ph13030037
Chicago/Turabian StyleZheng, Xunan, Zhengning Ma, and Dawei Zhang. 2020. "Synthesis of Imidazole-Based Medicinal Molecules Utilizing the van Leusen Imidazole Synthesis" Pharmaceuticals 13, no. 3: 37. https://doi.org/10.3390/ph13030037